CN107188830B - A kind of pyrethrin pesticide haptens and its preparation method and application - Google Patents
A kind of pyrethrin pesticide haptens and its preparation method and application Download PDFInfo
- Publication number
- CN107188830B CN107188830B CN201710466703.7A CN201710466703A CN107188830B CN 107188830 B CN107188830 B CN 107188830B CN 201710466703 A CN201710466703 A CN 201710466703A CN 107188830 B CN107188830 B CN 107188830B
- Authority
- CN
- China
- Prior art keywords
- haptens
- pyrethrin pesticide
- monoclonal antibody
- adds
- pyrethrin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000575 pesticide Substances 0.000 title claims abstract description 53
- VQXSOUPNOZTNAI-UHFFFAOYSA-N Pyrethrin I Natural products CC(=CC1CC1C(=O)OC2CC(=O)C(=C2C)CC=C/C=C)C VQXSOUPNOZTNAI-UHFFFAOYSA-N 0.000 title claims abstract description 52
- HYJYGLGUBUDSLJ-UHFFFAOYSA-N pyrethrin Natural products CCC(=O)OC1CC(=C)C2CC3OC3(C)C2C2OC(=O)C(=C)C12 HYJYGLGUBUDSLJ-UHFFFAOYSA-N 0.000 title claims abstract description 52
- VJFUPGQZSXIULQ-XIGJTORUSA-N pyrethrin II Chemical compound CC1(C)[C@H](/C=C(\C)C(=O)OC)[C@H]1C(=O)O[C@@H]1C(C)=C(C\C=C/C=C)C(=O)C1 VJFUPGQZSXIULQ-XIGJTORUSA-N 0.000 title claims abstract description 52
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- VEMKTZHHVJILDY-UXHICEINSA-N bioresmethrin Chemical class CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 VEMKTZHHVJILDY-UXHICEINSA-N 0.000 claims abstract description 12
- 238000001514 detection method Methods 0.000 claims abstract description 10
- 210000004408 hybridoma Anatomy 0.000 claims abstract description 6
- 230000028327 secretion Effects 0.000 claims abstract description 3
- 239000000427 antigen Substances 0.000 claims description 15
- 102000036639 antigens Human genes 0.000 claims description 15
- 108091007433 antigens Proteins 0.000 claims description 15
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 14
- 238000006243 chemical reaction Methods 0.000 claims description 12
- -1 Carboxyl pyrethroids Chemical compound 0.000 claims description 7
- 102000014914 Carrier Proteins Human genes 0.000 claims description 7
- 108010078791 Carrier Proteins Proteins 0.000 claims description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- 241001465754 Metazoa Species 0.000 claims description 6
- LVZWSLJZHVFIQJ-UHFFFAOYSA-N Cyclopropane Chemical compound C1CC1 LVZWSLJZHVFIQJ-UHFFFAOYSA-N 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 4
- 238000000926 separation method Methods 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 3
- 238000010828 elution Methods 0.000 claims description 3
- MHYCRLGKOZWVEF-UHFFFAOYSA-N ethyl acetate;hydrate Chemical compound O.CCOC(C)=O MHYCRLGKOZWVEF-UHFFFAOYSA-N 0.000 claims description 3
- 239000012074 organic phase Substances 0.000 claims description 3
- 229910002027 silica gel Inorganic materials 0.000 claims description 3
- 239000000741 silica gel Substances 0.000 claims description 3
- 229960001866 silicon dioxide Drugs 0.000 claims description 3
- 229910021529 ammonia Inorganic materials 0.000 claims 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims 1
- 238000003810 ethyl acetate extraction Methods 0.000 claims 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims 1
- 235000017557 sodium bicarbonate Nutrition 0.000 claims 1
- 210000004027 cell Anatomy 0.000 abstract description 19
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 abstract description 12
- OWZREIFADZCYQD-NSHGMRRFSA-N deltamethrin Chemical compound CC1(C)[C@@H](C=C(Br)Br)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 OWZREIFADZCYQD-NSHGMRRFSA-N 0.000 abstract description 5
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract description 4
- 239000000460 chlorine Substances 0.000 abstract description 4
- 229910052801 chlorine Inorganic materials 0.000 abstract description 4
- 244000005700 microbiome Species 0.000 abstract description 4
- 229960000490 permethrin Drugs 0.000 abstract description 4
- RLLPVAHGXHCWKJ-UHFFFAOYSA-N permethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-UHFFFAOYSA-N 0.000 abstract description 4
- 239000005936 tau-Fluvalinate Substances 0.000 abstract description 4
- INISTDXBRIBGOC-XMMISQBUSA-N tau-fluvalinate Chemical compound N([C@H](C(C)C)C(=O)OC(C#N)C=1C=C(OC=2C=CC=CC=2)C=CC=1)C1=CC=C(C(F)(F)F)C=C1Cl INISTDXBRIBGOC-XMMISQBUSA-N 0.000 abstract description 4
- ZXQYGBMAQZUVMI-RDDWSQKMSA-N (1S)-cis-(alphaR)-cyhalothrin Chemical compound CC1(C)[C@H](\C=C(/Cl)C(F)(F)F)[C@@H]1C(=O)O[C@@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 ZXQYGBMAQZUVMI-RDDWSQKMSA-N 0.000 abstract description 3
- 239000005910 lambda-Cyhalothrin Substances 0.000 abstract description 3
- 229920000728 polyester Polymers 0.000 abstract description 3
- 238000012216 screening Methods 0.000 abstract description 3
- 239000007788 liquid Substances 0.000 description 21
- 241000699666 Mus <mouse, genus> Species 0.000 description 15
- 238000000034 method Methods 0.000 description 14
- 239000000243 solution Substances 0.000 description 11
- 239000006228 supernatant Substances 0.000 description 11
- 238000002965 ELISA Methods 0.000 description 9
- 239000011248 coating agent Substances 0.000 description 9
- 238000000576 coating method Methods 0.000 description 9
- 206010003445 Ascites Diseases 0.000 description 8
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 7
- 239000012980 RPMI-1640 medium Substances 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 108010058846 Ovalbumin Proteins 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 229940092253 ovalbumin Drugs 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 238000003018 immunoassay Methods 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 108010088751 Albumins Proteins 0.000 description 3
- 102000009027 Albumins Human genes 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- 206010035226 Plasma cell myeloma Diseases 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 238000013019 agitation Methods 0.000 description 3
- 230000002860 competitive effect Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000003053 immunization Effects 0.000 description 3
- 238000002649 immunization Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 201000000050 myeloid neoplasm Diseases 0.000 description 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 210000004988 splenocyte Anatomy 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 239000012224 working solution Substances 0.000 description 3
- CUDYUNNRMLWYTR-UHFFFAOYSA-N 1-amino-2,2-dimethylcyclopropane-1-carboxylic acid Chemical compound CC1(C)CC1(N)C(O)=O CUDYUNNRMLWYTR-UHFFFAOYSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 108010049003 Fibrinogen Proteins 0.000 description 2
- 102000008946 Fibrinogen Human genes 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 108010071390 Serum Albumin Proteins 0.000 description 2
- 102000007562 Serum Albumin Human genes 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 210000000683 abdominal cavity Anatomy 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 150000008064 anhydrides Chemical class 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 230000007910 cell fusion Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229940012952 fibrinogen Drugs 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 108060003552 hemocyanin Proteins 0.000 description 2
- 230000002163 immunogen Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 230000001376 precipitating effect Effects 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 238000013517 stratification Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- AVMSWPWPYJVYKY-UHFFFAOYSA-N 2-Methylpropyl formate Chemical compound CC(C)COC=O AVMSWPWPYJVYKY-UHFFFAOYSA-N 0.000 description 1
- 241000256844 Apis mellifera Species 0.000 description 1
- SUZQPTKYCSADPP-UHFFFAOYSA-M C(CCCC)(=O)[O-].[Cl+] Chemical compound C(CCCC)(=O)[O-].[Cl+] SUZQPTKYCSADPP-UHFFFAOYSA-M 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 101100203936 Mus musculus Srpra gene Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 1
- 108010008038 Synthetic Vaccines Proteins 0.000 description 1
- MUUGCDGGIVCSDT-UHFFFAOYSA-N [NH4+].[NH4+].[O-]S([O-])(=O)=O.CCCCCCCC(O)=O Chemical compound [NH4+].[NH4+].[O-]S([O-])(=O)=O.CCCCCCCC(O)=O MUUGCDGGIVCSDT-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 238000011091 antibody purification Methods 0.000 description 1
- 210000003567 ascitic fluid Anatomy 0.000 description 1
- 238000004500 asepsis Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000007640 basal medium Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- QQODLKZGRKWIFG-QSFXBCCZSA-N cyfluthrin Chemical compound CC1(C)[C@@H](C=C(Cl)Cl)[C@H]1C(=O)O[C@@H](C#N)C1=CC=C(F)C(OC=2C=CC=CC=2)=C1 QQODLKZGRKWIFG-QSFXBCCZSA-N 0.000 description 1
- 229960001591 cyfluthrin Drugs 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- GBIHOLCMZGAKNG-CGAIIQECSA-N flucythrinate Chemical compound O=C([C@@H](C(C)C)C=1C=CC(OC(F)F)=CC=1)OC(C#N)C(C=1)=CC=CC=1OC1=CC=CC=C1 GBIHOLCMZGAKNG-CGAIIQECSA-N 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 210000004279 orbit Anatomy 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000004454 trace mineral analysis Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/38—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by esterified hydroxy groups
- C07C255/39—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by esterified hydroxy groups with hydroxy groups esterified by derivatives of 2,2-dimethylcyclopropane carboxylic acids, e.g. of chrysanthemumic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- C07K14/765—Serum albumin, e.g. HSA
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
Abstract
The present invention relates to a kind of haptens and its preparation method and application, and in particular to a kind of pyrethrin pesticide haptens and its preparation method and application.Based on the pyrethroids class monoclonal antibody hybridoma cell strain F-3-2 of pyrethrin pesticide haptens screening, it is preserved in China Committee for Culture Collection of Microorganisms's common micro-organisms center, deposit number is CGMCC No.13842.The pyrethroids class antibody titer of this cell strain secretion reaches 2 × 105Cross reacting rate with decis is 100%, cross reacting rate with lambda-cyhalothrin is 50.9%, cross reacting rate with taufluvalinate is 103.6%, cross reacting rate with cyfloxylate is 70.7%, and the cross reacting rate with penta polyester of chlorine is 74.4%, and the cross reacting rate with benzene Permethrin is 69.0%, condition is provided for the how remaining immune detection of pyrethrin pesticide, there is practical application value.
Description
Technical field
The present invention relates to a kind of haptens and its preparation method and application, and in particular to pyrethrin pesticide haptens and its system
Preparation Method and application belong to food safety technical field of immunological detection.
Background technique
Pyrethrin pesticide have the characteristics that insecticidal spectrum is wide, drug effect rapidly, it is long to light and thermally stable, efficacy time, agricultural,
The fields such as forestry, public health are widely used, but it has harm to the ecosystem and human health, especially to honeybee and aquatic
Biology has high toxicity.The World Health Organization (WHO) and FAO (Food and Agriculture Organization of the United Nation) (FAO) are residual on vegetables and fruits to pyrethrin pesticide
It stays and has formulated stringent limit standard, China has also formulated limit standard (GB 2763-2016) to such pesticide.
Currently, the detection method of pyrethrin pesticide is mainly chromatography, including gas-chromatography (GC), high performance liquid chromatography
(HPLC), mass spectrography (MS) and gas chromatography-mass spectrography (GC-MS) or Liquid Chromatography-Mass Spectrometry (HPLC-MS) etc..
Instrument analytical method has the advantages that high sensitivity, but expense is costly, and technical requirements are high, and it is a large amount of to be not suitable for on-site quick screening
Sample.
Immunoassay can make up all of above disadvantage, immunoassay be with specific recognition between antigen and antibody and
Trace analysis methods based on invertibity association reaction, since with high specificity, high sensitivity, simple, quick, expense is low
It the advantages that with live batch samples screening is suitable for, is used widely in the analysis fields such as environment and food safety.It builds
The key of the immunoassay method of vertical small molecule compound is can to prepare to have high-affinity and height to small molecule compound
Antibody selective, and the synthesis of haptens is the basis for preparing high-quality antibody.The key of hapten design is as much as possible
Retain the feature structure of former test substance, and introduces suitable linking arm and the activity with carrier protein couplet in position
Group.The introducing position of the linking arm of different structure, different coupling methods or linking arm, all influences the antibody of subsequent preparation
Sensitivity and specificity.In addition, as the same clan, family compound, a variety of pyrethrin pesticides are in food and the cumulative toxicity in environment
There is wide spectrum to know for serious implicit risk, therefore synthesizing efficient valence, the general antigen with pyrethroids class structural features, preparation
Other antibody becomes the emphasis of pyrethrin pesticide immunoassay research.
Summary of the invention
The purpose of the present invention is to provide a kind of pyrethrin pesticide haptens and preparation method thereof and the haptens and people
The monoclonal antibody that the conjugate that seralbumin is coupled is prepared as immunogen immune animal.It is verified through test data,
The monoclonal antibody of preparation is to decis, lambda-cyhalothrin, taufluvalinate, cyfloxylate, chlorine valerate, benzene Permethrin
6 kinds of pyrethrin pesticides have preferable detection sensitivity, can be used to establish the how remaining immunology detection side of pyrethrin pesticide
Method.
The purpose of the present invention is achieved by the following technical programs:
A kind of pyrethrin pesticide haptens, molecular structural formula are as follows:
The preparation method of above-mentioned pyrethrin pesticide haptens, includes the following steps:
[cyano-(3- phenoxy group)-methyl] 2 bromacetate 1.0g are taken, adds n,N-Dimethylformamide to dissolve, adds bicarbonate
Sodium 0.72g after mixing is sufficiently stirred, adds 1- amino -2,2- dimethyl cyclopropane carboxylic acid 0.45g, 60 DEG C are stirred to react 4h;Stop
Reaction adds water ethyl acetate to extract, and stratification, organic phase anhydrous sodium sulfate is dry, is evaporated, upper silicagel column, petroleum ether/acetic acid
Ethyl ester=1:1 elution separation, obtains cyclopropane carboxyl pyrethroids haptens 1.1g, as pyrethrin pesticide haptens, yield
97.35%.
Application of the above-mentioned pyrethrin pesticide haptens in immune detection, specifically includes by the pyrethrin pesticide haptens
The pyrethrin pesticide artificial antigen obtained with carrier protein couplet, and animal system is immunized by resulting pyrethrin pesticide artificial antigen
Standby monoclonal antibody.
Wherein the carrier protein be mouse serum albumin, thyroprotein, bovine serum albumin(BSA), albumin rabbit serum,
Human serum albumins, ovalbumin, hemocyanin or fibrinogen.
The monoclonal antibody is thin for the pyrethroids class monoclonal antibody hybridoma of CGMCC No.13842 by deposit number
Born of the same parents' strain F-3-2 secretion generates, more residual immune detections applied to pyrethrin pesticide.
The beneficial effects of the present invention are:
(1) pyrethrin pesticide haptens provided by the invention had both farthest remained the chemistry of pyrethrin pesticide parent nucleus
Structure, further through chemical synthesis transformation introduce can with protein be coupled-COOH, synthetic method is simple, purity, yield
It is higher;
(2) monoclonal antibody that animal obtains is immunized in the pyrethrin pesticide artificial antigen that the present invention is prepared, and potency reaches
To 2 × 105, illustrate that the antigen that the present invention synthesizes has excellent immunogenicity, completely remained during synthetic antigen
The prototype structure of hapten molecule;
(3) monoclonal antibody specificity provided by the invention is good, and the cross reacting rate with decis is 100%, with chlorine
The cross reacting rate of flucythrinate is 50.9%, and the cross reacting rate with taufluvalinate is 103.6%, with cyfloxylate
Cross reacting rate is 70.7%, and the cross reacting rate with penta polyester of chlorine is 74.4%, and the cross reacting rate with benzene Permethrin is
69.0%, it can be applied to more residual immune detections of pyrethrin pesticide.
Biological material specimens preservation: one plant of pyrethroids class monoclonal antibody hybridoma cell strain has been preserved in China Microbiological
Culture presevation administration committee common micro-organisms center, abbreviation CGMCC, address: Yard 1, BeiChen xi Road, Chaoyang District, Beijing City 3,
Institute of Microorganism, Academia Sinica, preservation date on May 05th, 2017, deposit number was CGMCC No.13842.
Detailed description of the invention
Fig. 1 pyrethrin pesticide hapten synthesis route map
Fig. 2 pyrethrin pesticide haptens hydrogen nuclear magnetic resonance spectrogram
Fig. 3 pyrethrin pesticide competitive ELISA canonical plotting
Specific embodiment
Present invention be described in more detail in the following with reference to the drawings and specific embodiments, it should be appreciated that these embodiments are only used for
Illustrate the present invention, and is not intended to limit the scope of the invention.Experimental method used in following embodiments unless otherwise specified,
It is conventional method;Used material, reagent etc., unless otherwise specified, for the reagent and material commercially obtained.
Embodiment 1: pyrethrin pesticide hapten synthesis and identification
The synthetic route of pyrethrin pesticide haptens is as shown in Fig. 1.
[cyano-(3- phenoxy group)-methyl] 2 bromacetate 1.0g are taken, adds n,N-Dimethylformamide to dissolve, adds bicarbonate
Sodium 0.72g after mixing is sufficiently stirred, adds 1- amino -2,2- dimethyl cyclopropane carboxylic acid 0.45g, 60 DEG C are stirred to react 4h;Stop
Reaction adds water ethyl acetate to extract, and stratification, organic phase anhydrous sodium sulfate is dry, is evaporated, upper silicagel column, petroleum ether/acetic acid
Ethyl ester=1:1 elution separation, obtains cyclopropane carboxyl pyrethroids haptens 1.1g, as pyrethrin pesticide haptens, yield
97.35%.
Above-mentioned haptens is taken to identify that the results are shown in attached figure 2 through nuclear magnetic resonance spectroscopy.1H-NMR(CDCl3, 300MHz) and δ: 11.00
(1H, s, COOH), 7.41 (2H, dd, ArH), 7.17 (1H, dd, ArH), 7.14 (2H, dd, ArH), 7.08 (2H, dd, ArH),
7.34 (2H, dd, ArH), 6.25 (1H, s, CH), 3.51 (2H, s, CH2), 2.0 (1H, s, NH), 0.94 (6H, s, CH3), 0.57
(1H, d, CH), 0.33 (1H, d, CH).In map, chemical shift δ=11.0 are carboxyl hydrogen resonance absorbing peak on compound,
7.08~7.41 be the absorption peak of hydrogen on phenyl ring, and 0.94 is the absorption peak of two methyl hydrogens, and 0.33~0.57 is on three-membered ring
Two hydrogen absorption peaks, in conjunction with other absorption peaks, it was demonstrated that hapten synthesis success.
Embodiment 2: the synthesis of pyrethrin pesticide artificial antigen and identification
It is even with mixed anhydride method and human serum albumins (HSA) using the carboxyl of pyrethrin pesticide haptens as active site
Connection prepares immunogene;It is coupled with carbodlimide method and ovalbumin (OVA), prepares coating antigen.
1. mixed anhydride method prepares immunogene
Cyclopropane carboxyl pyrethroids haptens 24mg is taken, dimethyl sulfoxide 0.5mL is added to dissolve, adds 20 μ L of triethylamine, stirring is mixed
Even, 20 μ L of chlorination iso-butyl formate stirs 30min, obtains haptens activating solution A liquid;HSA 100mg is taken, adds 0.1mol/L's
Phosphate buffer dissolution, obtains B liquid;A liquid is added drop-wise to dropwise in B liquid, 4h is stirred at room temperature, the phosphate of 0.01mol/L is slow
Fliud flushing is dialysed 3 days, is changed liquid 3 times daily, is obtained immunogene, -20 DEG C save backup.
2. carbodlimide method prepares coating antigen
Cyclopropane carboxyl pyrethroids haptens 10mg is taken, n,N-Dimethylformamide (DMF) 0.3mL is added to dissolve, adds carbon two sub-
Amine (EDC) 13mg stirs 30min, adds n-hydroxysuccinimide (NHS) 13mg, stirs 30min, obtains haptens activating solution A
Liquid;OVA 100mg is taken, adds the phosphate buffer of 0.1mol/L to dissolve, obtains B liquid;A liquid is added drop-wise to dropwise in B liquid, room temperature
4h is stirred, the phosphate buffer of 0.01mol/L dialyses 3 days, changes liquid 3 times daily, obtain coating antigen, -20 DEG C save backup.
Mouse serum albumin, thyroprotein, bovine serum albumin(BSA), the white egg of rabbit anteserum can also be used in the above method
White, hemocyanin or fibrinogen.
3. artificial antigen is identified
By carrier protein, pyrethrin pesticide haptens, pyrethrin pesticide hapten-carrier protein conjugate with pH's 7.4
PBS is made into the solution of 0.5mg/mL, is returned to zero with the PBS of 0.01mol/L pH7.4, with ultraviolet specrophotometer wavelength 200~
It is scanned within the scope of 800nm, obtains carrier protein, pyrethrin pesticide haptens, pyrethrin pesticide hapten-carrier protein conjugate
Absorption curve, and calculate its combine than.As a result, it has been found that different absorption curves occurs in three, show that pyrethrin pesticide half is anti-
Former successful with carrier protein couplet, the combination ratio of haptens and HSA are (17~21): 1, and the combination ratio of OVA is (15~20):
1。
Embodiment 3: preparation and purification of monoclonal antibody and CHARACTERISTICS IDENTIFICATION
1. animal immune
Take 6~8 weeks female Balb/c mouse 10 (be divided into A and two groups of B, every group 5) of health, initial immunity Freund
Freund's complete adjuvant emulsifies posterior neck dorsal sc multi-point injection, and every mouse immune dosage is 200 μ g immunogenes;Booster immunization is every later
The subcutaneous multi-point injection of the nape of the neck is primary within two weeks, and incomplete Freund's adjuvant is used in emulsification;Last time is immune to be replaced using physiological saline
Incomplete Freund's adjuvant, using intraperitoneal injection, injection dosage and front are identical several times.Specifically immune step is shown in Table 1.
1 mouse immune program of table
For the third time, four times, 7d after booster immunization take blood to mouse docking, and ELISA method measures mice serum potency, tool
Steps are as follows for body:
(1) coating antigen is done into 1:1000 dilution, every 100 μ L of hole coating with the carbonate buffer solution of 0.05mol/L pH9.6
ELISA Plate, 37 DEG C of incubation 2h, gets rid of coating buffer, with PBST washing 1 time, pats dry;
(2) 150 μ L confining liquids are added in every hole, and 37 DEG C of reaction 2h hypsokinesis deblocking liquid pat dry;
(3) 50 μ L are added with the antiserum of PBS doubling dilution, 25 DEG C of reaction 30min hypsokinesis dereaction liquid, with PBST in every hole
Washing 3~5 times, every minor tick 30s is patted dry;
(4) plus 100 hole μ L/ of the diluted ELIAS secondary antibody of PBS (1:1000), 25 DEG C of reaction 30min wash 3~5 with PBST
Secondary, every minor tick 30s is patted dry;
(5) substrate developing solution A liquid and each 50 μ L of B liquid is added in every hole, and 25 DEG C are protected from light 15min, and 50 μ are added in every hole
The H of L2mol/L2SO4Solution terminates reaction;
(6) microplate reader measures wavelength in the OD value of 450nm, with sample well OD450Extension rate close to 1 is used as the positive
The potency of serum.
2. cell fusion
(1) prepared by feeder cells: disconnected neck puts to death 8~10 week old Balb/c mouse, is immersed in 5min in 75% alcohol, immediately
It is put into superclean bench, abdomen is put in plate upward or is fixed in dissection plate.Mouse web portion skin is played with ophthalmic tweezers sub-folder
Skin cuts an osculum with scissors, pays attention to being sure not to break peritonaeum, in order to avoid peritoneal fluid outflow and pollution.Then use scissors to upper and lower two sides
Blunt separation is done, peritonaeum is sufficiently exposed.With cotton ball soaked in alcohol wiping peritonaeum disinfection.The basis 5mL RPMI-1640 is drawn with syringe
Culture solution injects mouse peritoneal, gently draws back syringe, shakes mouse leg and tail portion several times.Abdominal cavity is drawn back with original annotation emitter
Interior liquid injects centrifuge tube.It operates 3~4 times repeatedly.1000r/min is centrifuged 10min, abandons supernatant.It is complete with 20~50mL
Cell is resuspended in culture solution, and 100 holes μ L/ are added drop-wise to culture plate, it is spare to set incubator.
(2) prepared by splenocyte: 3d after booster immunization, takes immune Balb/c mouse, dislocates and put to death after eye socket blood sampling, 75%
Spleen is taken after sterilizing in alcohol, is removed connective tissue, is prepared splenocyte suspension, be transferred in 50mL centrifuge tube, add RPMI-1640
It is centrifuged 5min to 30mL, 1500~2000r/min, supernatant is abandoned, adds RPMI-1640 to 30mL, is counted stand-by.
(3) myeloma cell prepare: take good (viable count > 95%) myeloma cell of 3 bottles of growth conditions, by it is complete
It full blows down, is transferred in 50mL centrifuge tube, add RPMI-1640 to 30mL, 1500~2000r/min to be centrifuged 5min, abandon supernatant, add
RPMI-1640 to 30mL is counted stand-by.
(4) mixing with cells: splenocyte: myeloma cell=8:1, mixing, 1500~2000r/min are centrifuged 5min.
(5) cell fusion: the cell mixed is centrifuged, and dry supernatant sets 37 DEG C of water sedimentation cell block bullet at paste
1mL fusion agent is added in bath in 1min, and fusion agent is polyethylene glycol (PEG) 4000, acts on 2min, and be gently mixed cell,
The PEG nutrient solution of 20mL serum-free is added in subsequent 4min, 1000r/min is centrifuged 10min, abandons supernatant.It is complete with 20~50mL
Cell is resuspended in culture solution, and cover plant is set in incubator in 96 porocyte culture plates containing feeder cells, every 100 μ L of hole.
3. cell strain screens
When the 1/2~1/3 of cell length to bottom hole, antibody test can be carried out.It is thin to there is hybridoma using ELISA method
The culture hole of intracellular growth is screened, and screen in two steps: the first step first filters out positive cell hole, second step with indirect ELISA
Selecting a variety of pyrethrin pesticides is standard items, carries out inhibitory effect measurement to positive cell with indirect competitive ELISA.It selects to more
Kind of pyrethrin pesticide standard items all have the hole preferably inhibited, are subcloned using limiting dilution assay, with same method into
Row detection.In triplicate, the cell strain F-3-2 of energy stably excreting pyrethroids class monoclonal antibody can be obtained.The cell strain in
It is preserved in China Committee for Culture Collection of Microorganisms's common micro-organisms center (abbreviation CGMCC, ground on May 05th, 2017
Location: Datun Road, Chaoyang District, Beijing City, Institute of Microorganism, Academia Sinica, postcode 100101), deposit number CGMCC
No.13842。
4. prepared by ascites
Atoleine is injected into 6~8 weeks Balb/c mouse, 500 μ L/ are only.The hybridization of logarithmic growth phase will be in after 10 days
Oncocyte CGMCC No.13842 is collected with RPMI-1640 basal medium, and with blood counting chamber and microscopic counting, cell is dense
Degree is 1.0 × 106~1.5 × 106Within the scope of a/mL.Every mouse 0.5mL hybridoma CGMCC No.13842 is injected into
Abdominal cavity.Notice that observation is expanded in mouse web portion after a week, ascites is acquired in mouse peritoneal with asepsis injector, every one to two days
Acquisition is primary, is repeatedly acquired repeatedly until mouse natural death in this way.5000r/min is centrifuged 5min at 4 DEG C, collects supernatant, and
Remove the fat and albuminous membranae of the floating of ascites upper layer.
5. antibody purification
Monoclonal antibody is using octanoic acid-ammonium sulfate method purifying, the specific steps are as follows:
(1) ascites is taken out into thaw at RT from -20 DEG C of refrigerators.Ascites is filtered with double-layer filter paper, the preliminary fatty piece, thin of removing
Born of the same parents' fragment and other impurities.12000r/min is centrifuged 15min, takes supernatant, abandons precipitating.Precise volume ascites volume;
The ascites of (2) 1 parts of volumes and the acetate buffer magnetic agitation of 3 parts of volumes mix, with 2mol/L HCl tune pH
To 4.5~4.8;
(3) caprylic acid is slowly added under magnetic agitation, 1mL ascites adds 33 μ L caprylic acids, adds rear room temperature magnetic agitation
30min, 4 DEG C of standing 2h of postposition;
(4) 12000r/min is centrifuged 5min, takes supernatant, and filtrate is collected in double-layer filter paper filtering;
(5) filtrate volume is measured, the PBS of the 0.1mol/L pH7.4 of 1/10 volume is added, with 2mol/L NaOH (record
NaOH volume) adjust pH to 7.4;
(6) supernatant ice bath is pre-chilled, adds ammonium sulfate solids to 0.277g/mL, it is stirring while adding, and in being added in 30min,
Set 4 DEG C overnight;
(7) 12000r/min is centrifuged 15min, abandons supernatant.Precipitating is dissolved with the 0.01mol/L PBS of certain volume.Use PB
Dialysis changes 0.01mol/L PBS two days later and dialyses two days, collects dialyzate, and 12000r/min is centrifuged 15min, takes supernatant, set -20
DEG C save.
6. antibody titer measures
Use the potency of indirect ELISA method measurement antibody for 1:200000.Specific steps refer to above-mentioned 1. animal immune
In content.
7. antibody cross reaction measures
It is measured using indirect competitive ELISA method, specific steps are as follows:
(1) coating antigen is done into 1:1000 dilution, every 100 μ L of hole coating with the carbonate buffer solution of 0.05mol/L pH9.6
ELISA Plate, 37 DEG C of incubation 2h, gets rid of coating buffer, with PBST washing 1 time, pats dry;
(2) 150 μ L confining liquids are added in every hole, and 37 DEG C of reaction 2h hypsokinesis deblocking liquid pat dry;
(3) every hole be first added pyrethrin pesticide standard working solution that 50 μ L are serially diluted (concentration is respectively 0,1,3,9,27,
81 μ g/L), 50 μ L are added then with PBS and do the diluted monoclonal antibody of 1:200000,25 DEG C of reaction 30min hypsokinesis dereactions
Liquid, with PBST washing 3~5 times, every minor tick 30s is patted dry;
(4) plus 100 hole μ L/ of the diluted ELIAS secondary antibody of PBS (1:1000), 25 DEG C of reaction 30min wash 3~5 with PBST
Secondary, every minor tick 30s is patted dry;
(5) substrate developing solution A liquid and each 50 μ L of B liquid is added in every hole, and 25 DEG C are protected from light 15min, and 50 μ are added in every hole
The H of L2mol/L2SO4Solution terminates reaction;
(6) OD value of the microplate reader measurement wavelength in 450nm.
Using the logarithm of pyrethrin pesticide concentration as abscissa, with percentage absorbance value (each concentration standards OD value with not
The percentage of the quasi- sample wells OD value of mark-on) it is that ordinate draws standard curve, see attached drawing 3.With each 50% percentage absorbance value of curve
Mass concentration (IC50) cross reacting rate is calculated as follows, it the results are shown in Table 2, cross reacting rate is smaller, and antibody specificity is higher.
In formula:
Si--- cross reacting rate, %;
Y --- the IC of decis standard working solution curve50Value;
Z --- the IC of other pyrethrin pesticide standard working solution curves50Value.
2 cross reaction measurement result of table
Note: "-" indicates curve torsional deformation, is not used to calculate.
As shown in Table 2, pyrethrin pesticide monoclonal antibody is to decis, lambda-cyhalothrin, taufluvalinate, cyfluthrin
Pyrethroids, penta polyester of chlorine, benzene Permethrin have cross reaction, illustrate that the antibody can be used for the immune inspection of more residuals of pyrethrin pesticide
It surveys.
Claims (4)
1. a kind of pyrethrin pesticide artificial antigen, it is characterised in that be to be obtained by pyrethrin pesticide haptens with carrier protein couplet
's;Wherein, the preparation method of the pyrethrin pesticide haptens includes the following steps: to take [cyano-(3- phenoxy group)-methyl]-
2- bromacetate 1.0g, adds n,N-Dimethylformamide to dissolve, and adds sodium bicarbonate 0.72g, after mixing is sufficiently stirred, adds 1- ammonia
Base -2,2- dimethyl cyclopropane carboxylic acid 0.45g, 60 DEG C are stirred to react 4h;Stop reaction, adds water-ethyl acetate extraction, stand and divide
Layer, organic phase anhydrous sodium sulfate is dry, is evaporated, upper silicagel column, and petrol ether/ethyl acetate=1:1 elution separation obtains cyclopropane
Carboxyl pyrethroids haptens, as pyrethrin pesticide haptens, molecular structural formula are as follows:
2. the monoclonal antibody of animal preparation is immunized by pyrethrin pesticide artificial antigen described in claim 1.
3. monoclonal antibody as claimed in claim 2, it is characterised in that it is CGMCC No.13842 that it, which is by deposit number,
Pyrethroids class monoclonal antibody hybridoma cell strain F-3-2 secretion generates.
4. monoclonal antibody as claimed in claim 3 is remaining the application in immune detection more pyrethrin pesticide.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710466703.7A CN107188830B (en) | 2017-06-20 | 2017-06-20 | A kind of pyrethrin pesticide haptens and its preparation method and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710466703.7A CN107188830B (en) | 2017-06-20 | 2017-06-20 | A kind of pyrethrin pesticide haptens and its preparation method and application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107188830A CN107188830A (en) | 2017-09-22 |
CN107188830B true CN107188830B (en) | 2019-07-26 |
Family
ID=59878225
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710466703.7A Active CN107188830B (en) | 2017-06-20 | 2017-06-20 | A kind of pyrethrin pesticide haptens and its preparation method and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107188830B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106543163A (en) * | 2016-11-08 | 2017-03-29 | 佛山市飞时达新材料科技有限公司 | A kind of haptenic preparation method and applications of fluoxastrobin |
CN108535474A (en) * | 2018-03-16 | 2018-09-14 | 北方工业大学 | Time-resolved fluorescence test strip for detecting permethrin and application thereof |
CN108931646B (en) * | 2018-05-30 | 2021-04-27 | 中国烟草总公司郑州烟草研究院 | Test strip for detecting safrole and preparation method and application thereof |
CN111812316B (en) * | 2020-06-03 | 2022-11-18 | 北京勤邦生物技术有限公司 | Application of fenpropathrin artificial antigen in enzyme linked immunosorbent assay kit |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101434652A (en) * | 2008-12-05 | 2009-05-20 | 中国农业科学院油料作物研究所 | Pyrethroid pesticide artificial antigen, antibody and preparation thereof |
CN102901811B (en) * | 2012-10-20 | 2014-08-13 | 江南大学 | Pyrethroid hapten design based on computer molecular simulation technique and application |
CN105732788A (en) * | 2016-03-21 | 2016-07-06 | 贵州勤邦食品安全科学技术有限公司 | Preparation method and application of efficient cyhalothrin hapten |
-
2017
- 2017-06-20 CN CN201710466703.7A patent/CN107188830B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN107188830A (en) | 2017-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107188830B (en) | A kind of pyrethrin pesticide haptens and its preparation method and application | |
CN1317302C (en) | 2, 4-dichlorophen artificial antigen, and its preparing method and use | |
CN110498766B (en) | Fluazinam hapten, artificial antigen and antibody, and preparation method and application thereof | |
CN106093381B (en) | Rod method toxin rod method phenol monomethyl ether colloidal gold immuno-chromatography test paper strip | |
CN111333570B (en) | Haloxyfop hapten, artificial antigen and antibody as well as preparation method and application thereof | |
CN105044365B (en) | The preparation method of the time resolved fluoro-immunoassay test paper of detection enrofloxacin residual | |
CN110642793A (en) | Azoxystrobin hapten, artificial antigen and antibody, and preparation method and application thereof | |
CN1775806A (en) | 2, 4, 6-trichlorophen artificial antigen, and its preparing method and use | |
CN101182356A (en) | Clenbuterol complete antigen and method for preparing monoclonal antibody thereof | |
CN101100456A (en) | Fipronil artificial hapten, synthetic method for the same, and its antigen, antibody and use | |
CN110627726B (en) | Prochloraz hapten, artificial antigen and antibody, and preparation method and application thereof | |
CN106588805A (en) | Furaltadone metabolite (AMOZ) derivatization hapten, preparation method of artificial antigen and application of artificial antigen | |
CN103539853A (en) | Specific antibody for resisting atrazine herbicide | |
CN106831498A (en) | Furacilin metabolite SEM derivatizations haptens, the preparation method and applications of artificial antigen | |
CN106367396A (en) | Carbofuran monoclonal antibody hybridoma cell strain YH1 and application thereof | |
CN105301246A (en) | Time-resolved fluoroimmunoassay kit for detecting adprin as well as detecting method of time-resolved fluoroimmunoassay kit | |
CN107523554B (en) | One plant of hybridoma cell strain SS0708 for secreting Madumycin monoclonal antibody specific and its application | |
CN111943882B (en) | Pythium hapten, artificial antigen and antibody as well as preparation method and application thereof | |
CN105754954B (en) | One plant of imidacloprid monoclonal antibody hybridoma cell strain YH5 and its application | |
CN100570323C (en) | A kind of ractopamine column and its production and use | |
CN101747429A (en) | Specific antibody against pesticide meta-tolyl-N-methylcarbamate | |
CN1904613A (en) | Artificial antigen used for immune analysis of sulfanilamide multi kind residue and antibody and its preparation | |
CN101100457A (en) | Fipronil hapten compound, synthetic method and use thereof | |
CN1966523A (en) | Dursban monoclonal antibody preparing method | |
CN101993487B (en) | Immunogen and coatinggen of chloramphenicol and application thereof in collaurum test paper |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |